Inhaled COVID Vaccine Begins Recruitment for Phase-2 Human Trials
Researchers at McMaster University have started a phase-2 clinical trial on a next-generation, inhaled COVID-19 vaccine. The AeroVax study, supported by $8 million in funding from the Canadian Institutes of…